Outcomes of extracorporeal membrane oxygenation in adult patients with hypoxemic respiratory failure refractory to mechanical ventilation

Introduction: Extracorporeal membrane oxygenation (ECMO) is a mode of extracorporeal life support that has been used to support cardiopulmonary disease refractory to conventional therapy. The experience with the use of ECMO in acute hypoxemic respiratory failure is still limited. The aim of this stu...

Full description

Bibliographic Details
Main Authors: Elisabet Periche Pedra, Melinda Rita Koborzan, Fabrizio Sbraga, Arnau Blasco Lucas, David Toral Sepúlveda
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Respiratory Medicine Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007118302053
id doaj-cec3193f8f3e4c6a83b1fc5da7627cf0
record_format Article
spelling doaj-cec3193f8f3e4c6a83b1fc5da7627cf02020-11-25T01:01:28ZengElsevierRespiratory Medicine Case Reports2213-00712018-01-0125220224Outcomes of extracorporeal membrane oxygenation in adult patients with hypoxemic respiratory failure refractory to mechanical ventilationElisabet Periche Pedra0Melinda Rita Koborzan1Fabrizio Sbraga2Arnau Blasco Lucas3David Toral Sepúlveda4Intensive Care Unit, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Corresponding author. Intensive Care Unit, Hospital Universitario de Bellvitge, C/ Feixa Llarga s/n, E-08907 L'Hospitalet de Llobregat, Barcelona, Spain.Intensive Care Unit, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, SpainService of Cardiac Surgery, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, SpainService of Cardiac Surgery, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, SpainService of Cardiac Surgery, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, SpainIntroduction: Extracorporeal membrane oxygenation (ECMO) is a mode of extracorporeal life support that has been used to support cardiopulmonary disease refractory to conventional therapy. The experience with the use of ECMO in acute hypoxemic respiratory failure is still limited. The aim of this study was to report clinical outcomes in adult patients with acute hypoxemic respiratory failure refractory to mechanical ventilation treated with ECMO. Methods: Between July 2011 and October 2017, 18 adult patients with hypoxemic respiratory failure refractory to mechanical ventilation were admitted to the Intensive Care Unit of an acute care tertiary hospital in Barcelona, Spain. These patients were treated with ECMO as salvage respiratory therapy. Outcomes included clinical data, ventilatory and blood gas characteristics, survival, and complications. Results: Fifteen patients (83.3%) were previously treated in prone position. The indication of VV-ECMO was established at an early stage after a mean (SD) of 3.8 (2.5) days on mechanical ventilation. The mean duration of ECMO was 10.4 days, and 16 patients (88.9%) required venous cannulation, mostly femoral-internal jugular. The mean length of ICU stay was 27 days and the mean hospital stay was 42.1 days. The ICU survival rate was 55.5% (n = 10) and the hospital survival rate was 50% (n = 9). Conclusions: This clinical study in a small series of ICU patients treated with ECMO confirms the usefulness of this technique as a ventilatory support in patients with refractory hypoxemic respiratory failure. However, the indication of this procedure is also committed to an ethical reflection considering the possible futility of the measure on a case-by-case basis and associated complications. Keywords: Hypoxemia, Respiratory failure, Extracorporeal membrane oxygenation, salvage respiratory therapyhttp://www.sciencedirect.com/science/article/pii/S2213007118302053
collection DOAJ
language English
format Article
sources DOAJ
author Elisabet Periche Pedra
Melinda Rita Koborzan
Fabrizio Sbraga
Arnau Blasco Lucas
David Toral Sepúlveda
spellingShingle Elisabet Periche Pedra
Melinda Rita Koborzan
Fabrizio Sbraga
Arnau Blasco Lucas
David Toral Sepúlveda
Outcomes of extracorporeal membrane oxygenation in adult patients with hypoxemic respiratory failure refractory to mechanical ventilation
Respiratory Medicine Case Reports
author_facet Elisabet Periche Pedra
Melinda Rita Koborzan
Fabrizio Sbraga
Arnau Blasco Lucas
David Toral Sepúlveda
author_sort Elisabet Periche Pedra
title Outcomes of extracorporeal membrane oxygenation in adult patients with hypoxemic respiratory failure refractory to mechanical ventilation
title_short Outcomes of extracorporeal membrane oxygenation in adult patients with hypoxemic respiratory failure refractory to mechanical ventilation
title_full Outcomes of extracorporeal membrane oxygenation in adult patients with hypoxemic respiratory failure refractory to mechanical ventilation
title_fullStr Outcomes of extracorporeal membrane oxygenation in adult patients with hypoxemic respiratory failure refractory to mechanical ventilation
title_full_unstemmed Outcomes of extracorporeal membrane oxygenation in adult patients with hypoxemic respiratory failure refractory to mechanical ventilation
title_sort outcomes of extracorporeal membrane oxygenation in adult patients with hypoxemic respiratory failure refractory to mechanical ventilation
publisher Elsevier
series Respiratory Medicine Case Reports
issn 2213-0071
publishDate 2018-01-01
description Introduction: Extracorporeal membrane oxygenation (ECMO) is a mode of extracorporeal life support that has been used to support cardiopulmonary disease refractory to conventional therapy. The experience with the use of ECMO in acute hypoxemic respiratory failure is still limited. The aim of this study was to report clinical outcomes in adult patients with acute hypoxemic respiratory failure refractory to mechanical ventilation treated with ECMO. Methods: Between July 2011 and October 2017, 18 adult patients with hypoxemic respiratory failure refractory to mechanical ventilation were admitted to the Intensive Care Unit of an acute care tertiary hospital in Barcelona, Spain. These patients were treated with ECMO as salvage respiratory therapy. Outcomes included clinical data, ventilatory and blood gas characteristics, survival, and complications. Results: Fifteen patients (83.3%) were previously treated in prone position. The indication of VV-ECMO was established at an early stage after a mean (SD) of 3.8 (2.5) days on mechanical ventilation. The mean duration of ECMO was 10.4 days, and 16 patients (88.9%) required venous cannulation, mostly femoral-internal jugular. The mean length of ICU stay was 27 days and the mean hospital stay was 42.1 days. The ICU survival rate was 55.5% (n = 10) and the hospital survival rate was 50% (n = 9). Conclusions: This clinical study in a small series of ICU patients treated with ECMO confirms the usefulness of this technique as a ventilatory support in patients with refractory hypoxemic respiratory failure. However, the indication of this procedure is also committed to an ethical reflection considering the possible futility of the measure on a case-by-case basis and associated complications. Keywords: Hypoxemia, Respiratory failure, Extracorporeal membrane oxygenation, salvage respiratory therapy
url http://www.sciencedirect.com/science/article/pii/S2213007118302053
work_keys_str_mv AT elisabetperichepedra outcomesofextracorporealmembraneoxygenationinadultpatientswithhypoxemicrespiratoryfailurerefractorytomechanicalventilation
AT melindaritakoborzan outcomesofextracorporealmembraneoxygenationinadultpatientswithhypoxemicrespiratoryfailurerefractorytomechanicalventilation
AT fabriziosbraga outcomesofextracorporealmembraneoxygenationinadultpatientswithhypoxemicrespiratoryfailurerefractorytomechanicalventilation
AT arnaublascolucas outcomesofextracorporealmembraneoxygenationinadultpatientswithhypoxemicrespiratoryfailurerefractorytomechanicalventilation
AT davidtoralsepulveda outcomesofextracorporealmembraneoxygenationinadultpatientswithhypoxemicrespiratoryfailurerefractorytomechanicalventilation
_version_ 1725209233263165440